Pricing of drugs and donations: options for sustainable equity pricing
Authors: Pérez-Casas C.; Herranz E.; Ford N.
Source: Tropical Medicine & International Health, Volume 6, Number 11, November 2001 , pp. 960-964(5)
Effective medicines exist to treat or alleviate many diseases which predominate in the developing world and cause high mortality and morbidity rates. Price should not be an obstacle preventing access to these medicines. Increasingly, drug donations have been established by drug companies, but these are often limited in time, place or use. Measures exist which are more sustainable and will have a greater positive impact on peoples health. Principally, these are encouraging generic competition; adopting into national legislation and implementing TRIPS safeguards to gain access to cheaper sources of drugs; differential pricing; creating high volume or high demand through global and regional procurement; and supporting the production of quality generic drugs by developing countries through voluntary licenses if needed, and facilitating technology transfer.
Document Type: Research article
Publication date: 2001-11-01